It has come the publisher's attention that the original version of this article [1] unfortunately contained an error. In Table 3 Genotyping of FcγRIIIA 158V>F was performed by a newly developed PSQ method after pre-amplification of FcγRIIIA gene. Genotyping of FcγRIIA 131H>R was performed by T-ARMS PCR and SBT. Conventionally, the 158V>F variant corresponds to the G>T SNP [i.e. guanine corresponding to valine (V) and thymine corresponding to phenylalanine (F)] and the 131H>R SNP corresponds to the A>G SNP [i.e. adenine corresponding to histidine (H) and guanine corresponding to arginine (R)]
Comparison of FcγR genotypic and allelic frequencies between patients and control subjects was estimated using the Pearson's χ 2 test (P* value) and the Fisher's test (P° value), respectively. Statistical significance: P < 0.05 NEO neoadjuvant, MTS metastatic, CTR controls, HWE Hardy-Weinberg equilibrium. HWE was tested by the Pearson's χ 2 test (P < 0.05 indicates lack of HWE) 
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